VKTXViking Therapeutics Inc
$37.61
$0.64
(1.69%)
Closed $37.31
$0.30
(0.80%)
After Hours
EarningsJul 29
Mkt Cap$4.41B
Vol1.35M
Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026
Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026 Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026 PR Newswire SAN DIEGO, July 22, 2026 Conference Call Scheduled forWednesday, July 29, at 4:30 p.m. Eastern TimeSAN DIEGO...
PR Newswire
NVO Challenges LLY Ads in GLP-1 Battle: Why the Lawsuit Matters Now
Novo Nordisk sues LLY over high-profile ads promoting Zepbound and Mounjaro, arguing newer clinical data changes the comparison as the GLP-1 rivalry intensifies.
Zacks
Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm PR Newswire NEW YORK, July 21, 2026 NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...
PR Newswire
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up PR Newswire LAS VEGAS, July 21, 2026 Issued on behalf of Ava Bio, Inc. (OTCQB: AVAI)LAS...
PR Newswire
Does EU Approval of Wegovy Pill Change NVO's Competitive Story?
Novo Nordisk wins EU approval for the first GLP-1 obesity tablet, expanding Wegovy's reach, but tougher competition keeps the broader investment outlook in focus.
Zacks
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1
Key PointsViking Therapeutics just launched its next-gen weight loss program...
Nasdaq News: Markets
Should You Buy Viking Therapeutics Stock on the Dip? Wall Street Is Screaming "Yes."
Should You Buy Viking Therapeutics Stock on the Dip? Wall Street Is Screaming "Yes...
Yahoo! Finance: News
Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $37.08, representing a +1.95% change from its previous close.
Zacks
Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?
VKTX's Q2 report could hinge on VK2735 pipeline updates as investors await progress on obesity studies and maintenance dosing plans.
Zacks
Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Viking Therapeutics, Inc. (VKTX) reached $36.37 at the closing of the latest trading day, reflecting a -3.81% change compared to its last close.
Zacks
<
1
2
...
>
Advertisement|Remove ads.
GOOGL15
22
SMCI18
22
RKLB7
14Advertisement|Remove ads.